Exscientia Plc's Comment on Sales, Marketing and Customers
The company's customers and referral sources include healthcare providers such as prescribers, purchasers, formulary managers, physicians (including doctors, dentists, optometrists, podiatrists, and chiropractors), other healthcare professionals like physician assistants and nurse practitioners, and teaching hospitals. The markets served encompass federal healthcare programs including Medicare, Medicaid, and the Children’s Health Insurance Program. Business and financial arrangements with these customers are governed by federal and state healthcare laws and regulations, including the Federal Anti-kickback Statute, the False Claims Act, HIPAA, and the Physician Payments Sunshine Act.
In a groundbreaking announcement today, Exscientia plc (Nasdaq: EXAI) underscored its commitment to revolutionizing cancer treatment by unveiling new preclinical data concerning its precision-engineered LSD1 (lysine-specific demethylase 1) and MALT1 (mucosa-associated lymphoid tissue lymphoma translocation protein 1) inhibitors at the 36th EORTC-NCI-AACR Symposium 2024, held from October 23 to 25 in Barcelona, Spain. Dr. David Hallett, Interim Chief Executive Officer and Chief Scientific Officer of Exscientia, expressed enthusiasm regarding the program s advancements, highlighting the essential role these inhibitors could play as they progress toward clinical trials.The LSD1 and MALT1 inhibitors represent a ...
: The legal strains often overshadow pharmaceutical breakthroughs in the biopharmaceutical industry. The broad spectrum of legalities forms a labyrinth where corporate action, investor rights, and public protection collide at the confluence of pharmaceuticals and business securities. A recent manifestation of this complex relationship is the securities class action lawsuit filed against the British-based, Artificial Intelligence (AI) centric pharmaceutical company, Exscientia, a case lodged in the United States District Court for the District of New Jersey.On Groundwork: The Exscientia Securities Lawsuit During a span of approximately two years, starting from March 23, 2022, to February 12, 2024, a web of le...
Exscientia Plc’s Comment on Sales, Marketing and Customers
The company's customers and referral sources include healthcare providers such as prescribers, purchasers, formulary managers, physicians (including doctors, dentists, optometrists, podiatrists, and chiropractors), other healthcare professionals like physician assistants and nurse practitioners, and teaching hospitals. The markets served encompass federal healthcare programs including Medicare, Medicaid, and the Children’s Health Insurance Program. Business and financial arrangements with these customers are governed by federal and state healthcare laws and regulations, including the Federal Anti-kickback Statute, the False Claims Act, HIPAA, and the Physician Payments Sunshine Act.
Sources:
Exscientia Plc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Exscientia Plc’s corporate clients.
For your research, we’ve provided 9 tables on Exscientia Plc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
